KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $166.2 million.

  • Oscar Health's Current Deferred Revenue rose 12342.42% to $166.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $166.2 million, marking a year-over-year increase of 12342.42%. This contributed to the annual value of $166.2 million for FY2025, which is 12342.42% up from last year.
  • According to the latest figures from Q4 2025, Oscar Health's Current Deferred Revenue is $166.2 million, which was up 12342.42% from $77.1 million recorded in Q3 2025.
  • Oscar Health's 5-year Current Deferred Revenue high stood at $166.2 million for Q4 2025, and its period low was $56.2 million during Q3 2021.
  • Moreover, its 5-year median value for Current Deferred Revenue was $72.3 million (2021), whereas its average is $75.1 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first plummeted by 1793.03% in 2024, then soared by 12342.42% in 2025.
  • Oscar Health's Current Deferred Revenue (Quarter) stood at $75.0 million in 2021, then rose by 5.27% to $79.0 million in 2022, then decreased by 16.56% to $65.9 million in 2023, then rose by 12.85% to $74.4 million in 2024, then soared by 123.42% to $166.2 million in 2025.
  • Its Current Deferred Revenue stands at $166.2 million for Q4 2025, versus $77.1 million for Q3 2025 and $69.5 million for Q2 2025.